Words by Abi Scaife
Clinical trials of personalised cancer therapies will become more widely available, thanks to increased funding.
Tell me more.
29 experimental cancer medicine centres (ECMCs) in the UK will receive an incredible £43 million in funding over the next five years.
12 of these centres specialise in cancers that effect young people and children, and that pose difficulties for doctors.
Where has the money come from?
The funding comes from a partnership between Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Little Princess Trust.
Thanks to the incredible work of these charities, more people will have a chance at life.
What will the money go towards?
The money will help fund trials for new treatments, including drugs that encourage the immune system to attack tumours or cancerous cells.
These trials will help to assess personalised treatments, where the genetic makeup of the patient’s tumour is examined, to see if these are more effective than standard treatments.
This article aligns with the UN SDG Good Health and Wellbeing.
